Skip to content
Plant Peptides intermediate

Bowman-Birk Inhibitor: Oligopeptide Research Reference

Bowman-Birk Inhibitor, a bioactive peptide compound with documented applications in biomedical research, pharmacological studies, and therapeutic development

By Encyclopeptide Editorial | 1 min read
plant-peptides peptide oligopeptide

Overview

Bowman-Birk Inhibitor is a bioactive peptide with well-characterized properties and therapeutic applications. It is derived from Glycine max (Soybean).

Structure

PropertyValue
NameBowman-Birk Inhibitor
SequenceDVPLDVAQTFHLKPFCSLCLPGNKCDTCLKS
Length71 amino acids
Molecular Weight~8,000 Da
SourceGlycine max (Soybean)
CategoryPlant Bioactive Peptides

Mechanism of Action

Double-headed protease inhibitor binding both trypsin and chymotrypsin simultaneously

Bioactivity

Protease inhibitor, anti-cancer, anti-inflammatory

Therapeutic Potential

Cancer chemoprevention, COPD therapy, anti-inflammatory treatment

References

  • Wikipept Peptide Database
  • Primary literature (see individual entries)

Test Your Knowledge

Reinforce what you learned about Bowman-Birk Inhibitor: Oligopeptide Research Reference with interactive quizzes on Wikipept.

Take a Quiz on Wikipept